is tirzepatide a glp-1 Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of | Cardiovascular Diabetology Semaglutide Vs Tirzepatide | GLP
Description
C., Skene, R
This study seeks to systematically assess and combine existing human-based findings about skin conditions linked to GLP-1RA therapy
In early 2026, Roche paid $100 million to secure a non-exclusive patent licence from Structures subsidiary Gasherbrum Bio, covering intellectual property relevant to CT-996, the oral GLP-1 compound Roche acquired through its $2.7 billion buyout of Carmot Therapeutics in late 2023
Clinical Nutrition 37(3)
SURMOUNT-MMO, NCT05556512) (Table 3)
